- Third quarter 2022 net sales of $2,023 million, 15% higher on a reported basis and 19% higher excluding foreign exchange impacts compared to the same period in 2021
- Third quarter 2022 reported and adjusted EPS* were $1.59 and $1.73, respectively, compared to third quarter 2021 reported and adjusted EPS of $1.75 and 1.67, respectively
- The Company updates its outlook for full-year 2022 adjusted EPS to be in the range of $7.00-$7.45 versus the previous outlook of $6.90-$7.45
WESTCHESTER, Ill., Nov. 03, 2022 (GLOBE NEWSWIRE) — Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage manufacturing industry, today reported results for the third quarter of 2022. The results, reported in accordance with U.S. generally accepted accounting principles (“GAAP”) for 2022 and 2021, include items that are excluded from the non-GAAP financial measures that the Company presents.
“Ingredion delivered another strong quarter with net sales up 15%,” said Jim Zallie, Ingredion’s president and chief executive officer. “The results were driven by solid demand across both core and specialty ingredients combined with in-year, dynamic price management in each region led by our pricing centers of excellence. We fully offset higher input costs, expanded gross margins and delivered strong operating income growth.
“Specialty ingredients continued to grow double digits as we executed against our Driving Growth Roadmap, with net sales and gross profit margins higher across all four of our regions versus last year,” Zallie continued. “Among the highlights in the quarter, we commissioned our new Shandong, China production facility, more than doubling our local starch production capacity to serve this large and growing market. This well-timed expansion also enables us to leverage our new network capacity to support our European customers who are concerned about anticipated industry shortages for some starch products due to the severe summer drought. Additionally, supporting our sugar reduction growth platform, we received European Union approval for our bioconverted Reb M stevia solutions which further positions us to grow our PureCircle franchise.
“While the macro environment remains uncertain, our team continues to do a great job offsetting inflationary and foreign exchange headwinds while overcoming supply chain challenges to deliver growth. As we look forward, we are closely monitoring customers’ demand, and are currently working to ensure we meet their needs now and into the future,” Zallie concluded.
*Adjusted diluted earnings per share (“adjusted EPS”), adjusted operating income, adjusted effective income tax rate and adjusted diluted weighted average common shares outstanding are non-GAAP financial measures. See section II of the Supplemental Financial Information entitled “Non-GAAP Information” following the Condensed Consolidated Financial Statements included in this news release for a reconciliation of these non-GAAP financial measures to the most directly comparable GAAP measures.
Diluted Earnings Per Share (EPS)
| 3Q21 | 3Q22 | YTD21 | YTD22 | Reported EPS | $1.75 | $1.59 | $0.74 | $5.63 | Restructuring/Impairment costs | 0.10 | – | 0.25 | 0.05 | Acquisition/Integration costs | 0.06 | – | 0.09 | 0.01 | Impairment*** | (0.30) | – | 5.02 | – | Tax items and other matters | 0.06 | 0.14 | (0.52) | 0.11 | Adjusted EPS** | $1.67 | $1.73 | $5.58 | $5.80 |
Estimated factors affecting changes in Reported and Adjusted EPS
| 3Q22 | YTD22 | |
| Total items affecting EPS** | 0.06 | 0.22 |
| Total operating items | 0.33 | 0.51 |
| Margin | 0.47 | 0.89 |
| Volume | 0.01 | (0.14) |
| Foreign exchange | (0.12) | (0.23) |
| Other income | (0.03) | (0.01) |
| Total non-operating items | (0.27) | (0.29) |
| Other non-operating income | – | – |
| Financing costs | (0.04) | (0.07) |
| Shares outstanding | 0.03 | 0.06 |
| Non-controlling interests | (0.03) | (0.03) |
| Tax rate | (0.23) | (0.25) |
**Totals may not foot due to rounding; ***Related to the Argentina joint venture announcement, 2021 reported results reflect a $340 million assets held for sale impairment charge, net of a $20 million favorable adjustment made in the third quarter of 2021, including $311 million of cumulative translation losses.
Financial Highlights
- At September 30, 2022, total debt and cash including short-term investments were $2.4 billion and $298 million, respectively, versus $2.0 billion and $332 million, respectively, at December 31, 2021.
- Net financing costs for the third quarter were $24 million versus $20 million for the year-ago period.
- Reported and adjusted effective tax rates for the third quarter were 32.3 percent and 30.6 percent, respectively, compared to 22.2 percent and 21.5 percent, respectively, for the year-ago period. The increase in the reported effective income tax rate was primarily driven by U.S. international tax implications including foreign tax credits and an impairment charge adjustment in the third quarter of 2021.
- Year-to-date net capital expenditures were $196 million, up $10 million from the year-ago period.
Business Review
Total Ingredion
Net Sales
| $ in millions | 2021 | FX Impact |
Volume | Argentina JV Volume* |
Price mix | 2022 | Change | Change excl. FX |
| Third Quarter | 1,763 | (71) | 14 | (18) | 335 | 2,023 | 15% | 19% |
| Year-to-Date | 5,139 | (136) | 156 | (146) | 946 | 5,959 | 16% | 19% |
* Related to the Argentina joint venture announcement, 2021 reported results were part of the transferred business
Reported Operating Income
| $ in millions | 2021 | FX Impact |
Business Drivers |
Acquisition / Integration |
Restructuring / Impairment |
Other | 2022 | Change | Change excl. FX |
| Third Quarter | 172 | (10) | 38 | 3 | 8 | (29) | 182 | 6% | 12% |
| Year-to-Date | 224 | (21) | 68 | 0 | 18 | 316 | 605 | 170% | 179% |
Adjusted Operating Income
| $ in millions | 2021 | FX Impact | Business Drivers |
2022 | Change | Change excl. FX |
| Third Quarter | 163 | (10) | 38 | 191 | 17% | 23% |
| Year-to-Date | 572 | (21) | 68 | 619 | 8% | 12% |
Net Sales
- Third quarter and year-to-date net sales were up from the year-ago period. These increases were driven by strong price mix and volume, partially offset by lapping of prior year consolidated Argentina net sales volume. Excluding foreign exchange impacts, net sales were up 19% for the quarter and year-to-date.
Operating Income
- Third quarter reported and adjusted operating income were $182 million and $191 million, respectively, an increase of 6% and 17%, respectively, from the same period last year. The increase in reported operating income was driven by favorable price mix partially offset by the prior year favorable adjustment to the Argentina held for sale impairment. The increase in adjusted operating income was driven by strong price mix that more than offset higher corn and input costs. Excluding foreign exchange impacts, reported and adjusted operating income were up 12% and 23%, respectively, from the same period last year.
- Year-to-date reported and adjusted operating income were $605 million and $619 million, respectively, an increase of 170% and 8%, respectively, from the year-ago period. The increase in reported operating income was attributable to the prior year’s held for sale impairment charge related to the Argentina joint venture. The increase in adjusted operating income was driven by strong price mix that more than offset higher corn and input costs. Excluding foreign exchange impacts, reported and adjusted operating income were up 179% and 12%, respectively, from the same period last year.
North America
Net Sales
| $ in millions | 2021 | FX Impact |
Volume | Price mix |
2022 | Change | Change excl. FX |
| Third Quarter | 1,083 | (6) | (4) | 189 | 1,262 | 17% | 17% |
| Year-to-Date | 3,096 | (10) | 48 | 586 | 3,720 | 20% | 20% |
Segment Operating Income
| $ in millions | 2021 | FX Impact | Business Drivers | 2022 | Change | Change excl. FX |
| Third Quarter | 120 | 0 | 6 | 126 | 5% | 5% |
| Year-to-Date | 403 | (1) | 41 | 443 | 10% | 10% |
- Third quarter operating income for North America was $126 million, an increase of $6 million from the year-ago period, and year-to-date operating income was $443 million, an increase of $40 million from the year-ago period. For both the quarter and year-to-date, the increase was driven by favorable price mix that more than offset higher corn and input costs.
South America
Net Sales
| $ in millions | 2021 | FX Impact |
Volume | Argentina JV Volume* |
Price mix |
2022 | Change | Change excl. FX |
| Third Quarter | 260 | (9) | 7 | (18) | 53 | 293 | 13% | 16% |
| Year-to-Date | 801 | (2) | 30 | (146) | 152 | 835 | 4% | 4% |
* Related to the Argentina joint venture announcement, 2021 reported results were part of the transferred business
Segment Operating Income
| $ in millions | 2021 | FX Impact | Business Drivers |
2022 | Change | Change excl. FX |
| Third Quarter | 35 | (2) | 15 | 48 | 37% | 43% |
| Year-to-Date | 108 | 0 | 17 | 125 | 16% | 16% |
- Third quarter operating income for South America was $48 million, an increase of $13 million from the year-ago period, and year-to-date operating income was $125 million, an increase of $17 million from the year-ago period. For both the quarter and year-to-date, the increases were driven by favorable price mix and higher volumes that more than offset higher corn and input costs. Excluding foreign exchange impacts, segment operating income was up 43% and 16%, respectively, for the third quarter and year-to-date.
Asia-Pacific
Net Sales
| $ in millions | 2021 | FX Impact |
Volume | Price mix |
2022 | Change | Change excl. FX |
| Third Quarter | 245 | (23) | 14 | 42 | 278 | 13% | 23% |
| Year-to-Date | 728 | (54) | 56 | 95 | 825 | 13% | 21% |
Segment Operating Income
| $ in millions | 2021 | FX Impact | Business Drivers |
2022 | Change | Change excl. FX |
| Third Quarter | 21 | (3) | 9 | 27 | 29% | 43% |
| Year-to-Date | 70 | (7) | 7 | 70 | 0% | 10% |
- Third quarter operating income for Asia-Pacific was $27 million, up $6 million from the year-ago period, and year-to-date operating income was $70 million, flat compared to the year-ago period. For both the quarter and year-to-date, the change was driven by favorable price mix that more than offset higher input costs and foreign exchange impacts. Excluding foreign exchange impacts, segment operating income was up 43% and 10%, respectively, for the third quarter and year-to-date.
Europe, Middle East, and Africa (EMEA)
Net Sales
| $ in millions | 2021 | FX Impact |
Volume | Price mix |
2022 | Change | Change excl. FX |
| Third Quarter | 175 | (33) | (3) | 51 | 190 | 9% | 27% |
| Year-to-Date | 514 | (70) | 22 | 113 | 579 | 13% | 26% |
Segment Operating Income
| $ in millions | 2021 | FX Impact | Business Drivers | 2022 | Change | Change excl. FX |
| Third Quarter | 23 | (5) | 12 | 30 | 30% | 52% |
| Year-to-Date | 86 | (13) | 17 | 90 | 5% | 20% |
- Third quarter operating income for EMEA was $30 million, up $7 million from the year-ago period, and year-to-date operating income was $90 million, up $4 million from the prior-year period. For both the third quarter and year-to-date, favorability in Europe was partially offset by challenges in Pakistan and foreign exchange impacts across the region. Excluding foreign exchange impacts, third quarter and year-to-date segment operating income was up 52% and 20%, respectively.
Dividends and Share Repurchases
For the first three quarters of 2022, the Company has paid total dividends of $133 million, and in the third quarter declared a quarterly dividend of $0.71 per share payable in the fourth quarter. This was a 9% increase from the prior dividend and is the eighth consecutive annual increase. During the quarter, the Company repurchased $29 million of outstanding shares of common stock, bringing Ingredion’s total share repurchases for the first three quarters of 2022 to $112 million. On September 26, 2022, the Company authorized a new stock repurchase program for up to 6 million shares through December 2025, replacing the previous program. Ingredion considers return of value to shareholders through cash dividends and share repurchases as part of its capital allocation strategy to support total shareholder return.
2022 Full-Year Outlook
The Company now expects its outlook for full-year 2022 reported EPS to be in the range of $6.90 to $7.20. Adjusted EPS is now expected to be in the range of $7.00 to $7.45, compared to adjusted EPS of $6.67 in 2021 and versus the previous outlook of $6.90 to $7.45. This expectation excludes acquisition-related integration and restructuring costs, as well as any potential impairment costs.
The Company expects full-year 2022 net sales to be up mid-double digits and adjusted operating income to be up low-double digits.
Compared to last year, the 2022 full-year outlook assumes the following: North America operating income is expected to be up low to mid-double digits, driven by favorable price mix more than offsetting higher corn and other input costs; South America operating income is expected to now be up high double-digits, driven by favorable price mix; Asia-Pacific operating income is expected to now be up mid-single digits, driven by PureCircle growth; and EMEA operating income is expected to now be flat to up low single-digits, driven by favorable price mix partially offset by higher input costs and foreign exchange impacts. Corporate costs are expected to be up mid-single digits.
For full-year 2022, the Company now expects a reported effective tax rate of 28.0 percent to 31.5 percent and an adjusted effective tax rate of 28.5 percent to 29.5 percent.
Cash from operations for full-year 2022 is now expected to be in the range of $225 million to $275 million, which reflects an anticipated increase in our working capital balances due to higher corn costs. Capital expenditures for the full year are expected to be between $290 million and $320 million.
Conference Call and Webcast Details
Ingredion will host a conference call on Thursday, November 3, 2022, at 8 a.m. Central Time / 9 a.m. Eastern Time, hosted by Jim Zallie, president and chief executive officer, and Jim Gray, executive vice president and chief financial officer. The call will be webcast in real time and can be accessed at https://ir.
About the Company
Ingredion Incorporated (NYSE: INGR) headquartered in the suburbs of Chicago, is a leading global ingredient solutions provider serving customers in more than 120 countries. With 2021 annual net sales of $6.9 billion, the Company turns grains, fruits, vegetables and other plant-based materials into value-added ingredient solutions for the food, beverage, animal nutrition, brewing and industrial markets. With Ingredion’s Idea Labs® innovation centers around the world and approximately 12,000 employees, the Company co-creates with customers and fulfills its purpose of bringing the potential of people, nature and technology together to make life better. Visit ingredion.com for more information and the latest Company news.
Forward-Looking Statements
This news release contains or may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends these forward-looking statements to be covered by the safe harbor provisions for such statements.
Forward-looking statements include, among others, any statements regarding the Company’s expectations for full-year 2022 net sales, adjusted operating income, reported and adjusted EPS, segment operating income, reported and adjusted effective tax rates, cash flow from operations, and capital expenditures, and any other statements regarding the Company’s prospects and its future operations, financial condition, net sales, operating income, volumes, corporate costs, tax rates, capital expenditures, cash flows, expenses or other financial items, including management’s plans or strategies and objectives for any of the foregoing, and any assumptions, expectations or beliefs underlying any of the foregoing.
These statements can sometimes be identified by the use of forward-looking words such as “may,” “will,” “should,” “anticipate,” “assume,” “believe,” “plan,” “project,” “estimate,” “expect,” “intend,” “continue,” “pro forma,” “forecast,” “outlook,” “propels,” “opportunities,” “potential,” “provisional,” or other similar expressions or the negative thereof. All statements other than statements of historical facts in this news release or referred to in this news release are “forward-looking statements.”
These statements are based on current circumstances or expectations, but are subject to certain inherent risks and uncertainties, many of which are difficult to predict and beyond our control. Although we believe our expectations expressed or implied in these forward-looking statements are based on reasonable assumptions, investors are cautioned that no assurance can be given that our expectations will prove correct.
Actual results and developments may differ materially from the expectations expressed in or implied by these statements, based on various risks and uncertainties, including the impact of COVID-19 on the demand for our products and our financial results; changing consumption preferences relating to high fructose corn syrup and other products we make; the effects of global economic conditions and the general political, economic, business, and market conditions that affect customers and consumers in the various geographic regions and countries in which we buy our raw materials or manufacture or sell our products, including, particularly, economic, currency, and political conditions in South America and economic and political conditions in Europe, and the impact these factors may have on our sales volumes, the pricing of our products and our ability to collect our receivables from customers; future purchases of our products by major industries which we serve and from which we derive a significant portion of our sales, including, without limitation, the food, beverage, animal nutrition, and brewing industries; the uncertainty of acceptance of products developed through genetic modification and biotechnology; our ability to develop or acquire new products and services at rates or of qualities sufficient to gain market acceptance; increased competitive and/or customer pressure in the corn-refining industry and related industries, including with respect to the markets and prices for our primary products and our co-products, particularly corn oil; the availability of raw materials, including potato starch, tapioca, gum Arabic, and the specific varieties of corn upon which some of our products are based, and our ability to pass along potential increases in the cost of corn or other raw materials to customers; energy costs and availability, including energy issues in Pakistan; our ability to contain costs, achieve budgets, and realize expected synergies, including with respect to our ability to complete planned maintenance and investment projects on time and on budget as well as with respect to freight and shipping costs; the effects of climate change and legal, regulatory, and market measures to address climate change; our ability to successfully identify and complete acquisitions or strategic alliances on favorable terms as well as our ability to successfully integrate acquired businesses or implement and maintain strategic alliances and achieve anticipated synergies with respect to all of the foregoing; operating difficulties at our manufacturing facilities; the behavior of financial and capital markets, including with respect to foreign currency fluctuations, fluctuations in interest and exchange rates and market volatility and the associated risks of hedging against such fluctuations; effects of the conflict between Russia and Ukraine, including impacts on the availability and prices of raw materials and energy supplies and volatility in exchange and interest rates; our ability to attract, develop, motivate, and maintain good relationships with our workforce; the impact on our business of natural disasters, war, threats or acts of terrorism, the outbreak or continuation of pandemics such as COVID-19, or the occurrence of other significant events beyond our control; the impact of impairment charges on our goodwill or long-lived assets; changes in government policy, law, or regulation and costs of legal compliance, including compliance with environmental regulation; changes in our tax rates or exposure to additional income tax liability; increases in our borrowing costs that could result from increased interest rates; our ability to raise funds at reasonable rates and other factors affecting our access to sufficient funds for future growth and expansion; security breaches with respect to information technology systems, processes, and sites; volatility in the stock market and other factors that could adversely affect our stock price; risks affecting the continuation of our dividend policy; and our ability to maintain effective internal control over financial reporting.
Our forward-looking statements speak only as of the date on which they are made and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of the statement as a result of new information or future events or developments. If we do update or correct one or more of these statements, investors and others should not conclude that we will make additional updates or corrections. For a further description of these and other risks, see “Risk Factors” and other information included in our Annual Report on Form 10-K for the year ended December 31, 2021, our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2022, and our subsequent reports on Form 10-Q and Form 8-K filed with the Securities and Exchange Commission.
| Ingredion Incorporated | ||||||||||||||||||||||
| Condensed Consolidated Statements of Income | ||||||||||||||||||||||
| (Unaudited) | ||||||||||||||||||||||
| (in millions, except per share amounts) | Three Months Ended September 30, | Change % |
Nine Months Ended September 30, |
Change % |
||||||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
| Net sales | $ | 2,023 | $ | 1,763 | 15 | % | $ | 5,959 | $ | 5,139 | 16 | % | ||||||||||
| Cost of sales | 1,649 | 1,440 | 4,816 | 4,098 | ||||||||||||||||||
| Gross profit | 374 | 323 | 16 | % | 1,143 | 1,041 | 10 | % | ||||||||||||||
| Operating expenses | 180 | 164 | 10 | % | 528 | 484 | 9 | % | ||||||||||||||
| Other operating expense (income) | 10 | (1 | ) | 4 | (29 | ) | ||||||||||||||||
| Restructuring/impairment charges and related adjustments | 2 | (12 | ) | 6 | 362 | |||||||||||||||||
| Operating income | 182 | 172 | 6 | % | 605 | 224 | 170 | % | ||||||||||||||
| Financing costs | 24 | 20 | 65 | 58 | ||||||||||||||||||
| Other non-operating (income) | (3 | ) | (1 | ) | (4 | ) | (4 | ) | ||||||||||||||
| Income before income taxes | 161 | 153 | 5 | % | 544 | 170 | 220 | % | ||||||||||||||
| Provision for income taxes | 52 | 34 | 157 | 113 | ||||||||||||||||||
| Net income | 109 | 119 | (8 | %) | 387 | 57 | 579 | % | ||||||||||||||
| Less: Net income attributable to non-controlling interests | 3 | 1 | 9 | 7 | ||||||||||||||||||
| Net income attributable to Ingredion | $ | 106 | $ | 118 | (10 | %) | $ | 378 | $ | 50 | 656 | % | ||||||||||
| Earnings per common share attributable to Ingredion | ||||||||||||||||||||||
| common shareholders: | ||||||||||||||||||||||
| Weighted average common shares outstanding: | ||||||||||||||||||||||
| Basic | 65.8 | 67.0 | 66.4 | 67.2 | ||||||||||||||||||
| Diluted | 66.6 | 67.6 | 67.1 | 67.8 | ||||||||||||||||||
| Earnings per common share of Ingredion: | ||||||||||||||||||||||
| Basic | $ | 1.61 | $ | 1.76 | (9 | %) | $ | 5.69 | $ | 0.74 | 669 | % | ||||||||||
| Diluted | $ | 1.59 | $ | 1.75 | (9 | %) | $ | 5.63 | $ | 0.74 | 661 | % | ||||||||||
| Ingredion Incorporated | ||||||||||
| Condensed Consolidated Balance Sheets | ||||||||||
| (in millions, except share and per share amounts) | September 30, 2022 | December 31, 2021 | ||||||||
| (Unaudited) | ||||||||||
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash and cash equivalents | $ | 294 | $ | 328 | ||||||
| Short-term investments | 4 | 4 | ||||||||
| Accounts receivable – net | 1,406 | 1,130 | ||||||||
| Inventories | 1,500 | 1,172 | ||||||||
| Prepaid expenses | 64 | 63 | ||||||||
| Total current assets | 3,268 | 2,697 | ||||||||
| Property, plant and equipment – net | 2,308 | 2,423 | ||||||||
| Intangible assets – net | 1,286 | 1,348 | ||||||||
| Other assets | 541 | 531 | ||||||||
| Total assets | $ | 7,403 | $ | 6,999 | ||||||
| Liabilities and equity | ||||||||||
| Current liabilities | ||||||||||
| Short-term borrowings | $ | 709 | $ | 308 | ||||||
| Accounts payable and accrued liabilities | 1,240 | 1,204 | ||||||||
| Total current liabilities | 1,949 | 1,512 | ||||||||
| Long-term debt | 1,739 | 1,738 | ||||||||
| Other non-current liabilities | 536 | 524 | ||||||||
| Total liabilities | 4,224 | 3,774 | ||||||||
| Share-based payments subject to redemption | 43 | 36 | ||||||||
| Redeemable non-controlling interests | 56 | 71 | ||||||||
| Equity | ||||||||||
| Ingredion stockholders’ equity: | ||||||||||
| Preferred stock – authorized 25,000,000 shares – $0.01 par value, none issued | – | – | ||||||||
| Common stock – authorized 200,000,000 shares – $0.01 par value, 77,810,875 | ||||||||||
| shares issued at September 30, 2022 and December 31, 2021 | 1 | 1 | ||||||||
| Additional paid-in capital | 1,133 | 1,158 | ||||||||
| Less: Treasury stock (common stock; 12,258,900 and 11,154,203 shares | ||||||||||
| at September 30, 2022 and December 31, 2021, respectively) at cost | (1,159 | ) | (1,061 | ) | ||||||
| Accumulated other comprehensive loss | (1,052 | ) | (897 | ) | ||||||
| Retained earnings | 4,143 | 3,899 | ||||||||
| Total Ingredion stockholders’ equity | 3,066 | 3,100 | ||||||||
| Non-redeemable non-controlling interests | 14 | 18 | ||||||||
| Total equity | 3,080 | 3,118 | ||||||||
| Total liabilities and equity | $ | 7,403 | $ | 6,999 | ||||||
| Ingredion Incorporated | ||||||||||
| Condensed Consolidated Statements of Cash Flows | ||||||||||
| (Unaudited) | ||||||||||
| Nine Months Ended September 30, |
||||||||||
| (in millions) | 2022 | 2021 | ||||||||
| Cash provided by operating activities: | ||||||||||
| Net income | $ | 387 | $ | 57 | ||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||
| Depreciation and amortization | 160 | 155 | ||||||||
| Mechanical stores expense | 42 | 40 | ||||||||
| Impairment on disposition of assets | – | 340 | ||||||||
| Deferred income taxes | (3 | ) | (25 | ) | ||||||
| Margin accounts | (11 | ) | (34 | ) | ||||||
| Changes in other trade working capital | (578 | ) | (258 | ) | ||||||
| Other | 83 | (16 | ) | |||||||
| Cash provided by operating activities | 80 | 259 | ||||||||
| Cash used for investing activities: | ||||||||||
| Capital expenditures and mechanical stores purchases | (203 | ) | (203 | ) | ||||||
| Proceeds from disposal of manufacturing facilities and properties | 7 | 17 | ||||||||
| Payments for acquisitions, net of cash acquired | (7 | ) | (40 | ) | ||||||
| Other | 1 | (12 | ) | |||||||
| Cash used for investing activities | (202 | ) | (238 | ) | ||||||
| Cash provided by (used for) financing activities: | ||||||||||
| Proceeds from (payments on) borrowings, net | 34 | (390 | ) | |||||||
| Commercial paper borrowings, net | 372 | 350 | ||||||||
| Repurchases of common stock, net | (112 | ) | (68 | ) | ||||||
| Purchases of non-controlling interests | (40 | ) | – | |||||||
| Issuances of common stock for share-based compensation, net of settlements | 1 | 10 | ||||||||
| Dividends paid, including to non-controlling interests | (133 | ) | (138 | ) | ||||||
| Cash provided by (used for) financing activities | 122 | (236 | ) | |||||||
| Effect of foreign exchange rate changes on cash | (34 | ) | (16 | ) | ||||||
| Decrease in cash and cash equivalents | (34 | ) | (231 | ) | ||||||
| Cash and cash equivalents, beginning of period | 328 | 665 | ||||||||
| Cash and cash equivalents, end of period | $ | 294 | $ | 434 | ||||||
| Ingredion Incorporated | ||||||||||||||||||||||||||||
| Supplemental Financial Information | ||||||||||||||||||||||||||||
| (Unaudited) | ||||||||||||||||||||||||||||
| I. Geographic Information of Net Sales and Operating Income | ||||||||||||||||||||||||||||
| (in millions, except for percentages) | Three Months Ended September 30, |
Change Excl. FX |
Nine Months Ended September 30, |
Change Excl. FX |
||||||||||||||||||||||||
| 2022 | 2021 | Change | 2022 | 2021 | Change |
|||||||||||||||||||||||
| Net Sales | ||||||||||||||||||||||||||||
| North America | $ | 1,262 | $ | 1,083 | 17 | % | 17 | % | $ | 3,720 | $ | 3,096 | 20 | % | 20 | % | ||||||||||||
| South America | 293 | 260 | 13 | % | 16 | % | 835 | 801 | 4 | % | 4 | % | ||||||||||||||||
| Asia-Pacific | 278 | 245 | 13 | % | 23 | % | 825 | 728 | 13 | % | 21 | % | ||||||||||||||||
| EMEA | 190 | 175 | 9 | % | 27 | % | 579 | 514 | 13 | % | 26 | % | ||||||||||||||||
| Total Net Sales | $ | 2,023 | $ | 1,763 | 15 | % | 19 | % | $ | 5,959 | $ | 5,139 | 16 | % | 19 | % | ||||||||||||
| Operating Income | ||||||||||||||||||||||||||||
| North America | $ | 126 | $ | 120 | 5 | % | 5 | % | $ | 443 | $ | 403 | 10 | % | 10 | % | ||||||||||||
| South America | 48 | 35 | 37 | % | 43 | % | 125 | 108 | 16 | % | 16 | % | ||||||||||||||||
| Asia-Pacific | 27 | 21 | 29 | % | 43 | % | 70 | 70 | 0 | % | 10 | % | ||||||||||||||||
| EMEA | 30 | 23 | 30 | % | 52 | % | 90 | 86 | 5 | % | 20 | % | ||||||||||||||||
| Corporate | (40 | ) | (36 | ) | (11 | %) | (11 | %) | (109 | ) | (95 | ) | (15 | %) | (15 | %) | ||||||||||||
| Sub-total | 191 | 163 | 17 | % | 23 | % | 619 | 572 | 8 | % | 12 | % | ||||||||||||||||
| Acquisition/integration costs | – | (3 | ) | (1 | ) | (1 | ) | |||||||||||||||||||||
| Restructuring/impairment charges | – | (8 | ) | (4 | ) | (22 | ) | |||||||||||||||||||||
| Impairment on disposition of assets | – | 20 | – | (340 | ) | |||||||||||||||||||||||
| Other matters | (9 | ) | – | (9 | ) | 15 | ||||||||||||||||||||||
| Total Operating Income | $ | 182 | $ | 172 | 6 | % | 12 | % | $ | 605 | $ | 224 | 170 | % | 179 | % | ||||||||||||
| II. Non-GAAP Information | |||||||||||||||||||||||||||
| To supplement the consolidated financial results prepared in accordance with U.S. generally accepted accounting principles (“GAAP”), we use non-GAAP historical financial measures, which exclude certain GAAP items such as acquisition and integration costs, restructuring and impairment costs, Mexico tax (benefit) provision, and other specified items. We generally use the term “adjusted” when referring to these non-GAAP amounts. | |||||||||||||||||||||||||||
| Management uses non-GAAP financial measures internally for strategic decision making, forecasting future results and evaluating current performance. By disclosing non-GAAP financial measures, management intends to provide investors with a more meaningful, consistent comparison of our operating results and trends for the periods presented. These non-GAAP financial measures are used in addition to and in conjunction with results presented in accordance with GAAP and reflect an additional way of viewing aspects of our operations that, when viewed with our GAAP results, provide a more complete understanding of factors and trends affecting our business. These non-GAAP measures should be considered as a supplement to, and not as a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP. | |||||||||||||||||||||||||||
| Non-GAAP financial measures are not prepared in accordance with GAAP; so our non-GAAP information is not necessarily comparable to similarly titled measures presented by other companies. A reconciliation of each non-GAAP financial measure to the most comparable GAAP measure is provided in the tables below. | |||||||||||||||||||||||||||
| Ingredion Incorporated | |||||||||||||||||||||||||||
| Reconciliation of GAAP Net Income attributable to Ingredion and Diluted Earnings Per Share (“EPS”) to | |||||||||||||||||||||||||||
| Non-GAAP Adjusted Net Income attributable to Ingredion and Adjusted Diluted EPS | |||||||||||||||||||||||||||
| (Unaudited) | |||||||||||||||||||||||||||
| Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended | ||||||||||||||||||||||||
| September 30, 2022 | September 30, 2021 | September 30, 2022 | September 30, 2021 | ||||||||||||||||||||||||
| (in millions) | Diluted EPS | (in millions) | Diluted EPS | (in millions) | Diluted EPS | (in millions) | Diluted EPS | ||||||||||||||||||||
| Net income attributable to Ingredion | $ | 106 | $ | 1.59 | $ | 118 | $ | 1.75 | $ | 378 | $ | 5.63 | $ | 50 | $ | 0.74 | |||||||||||
| Add back: | |||||||||||||||||||||||||||
| Acquisition/integration costs, net of $ – million of income taxes for the three and nine months ended September 30, 2022, and inclusive of $ – million and $4 million of income tax expense for the three and nine months ended September 30, 2021, respectively (i) | – | – | 4 | 0.06 | 1 | 0.01 | 6 | 0.09 | |||||||||||||||||||
| Restructuring/impairment charges, net of $ – million and $1 million of income tax benefit for the three and nine months ended September 30, 2022, respectively and $1 million and $5 million for the three and nine months ended September 30, 2021, respectively (ii) | – | – | 7 | 0.10 | 3 | 0.05 | 17 | 0.25 | |||||||||||||||||||
| Impairment on disposition of assets, net of $ – million of income tax benefit for the three and nine months ended September 30, 2021 (iii) | – | – | (20 | ) | (0.30 | ) | – | – | 340 | 5.02 | |||||||||||||||||
| Other matters, net of income tax expense of $2 million for the three and nine months ended September 30, 2022, and $ – million and $5 million for the three and nine months ended September 30, 2021, respectively (iv) | 7 | 0.11 | – | – | 7 | 0.11 | (10 | ) | (0.15 | ) | |||||||||||||||||
| Tax (benefit) provision – Mexico (v) | (1 | ) | (0.02 | ) | 5 | 0.07 | (2 | ) | (0.03 | ) | 4 | 0.06 | |||||||||||||||
| Other tax matters (vi) | 3 | 0.05 | (1 | ) | (0.01 | ) | 2 | 0.03 | (29 | ) | (0.43 | ) | |||||||||||||||
| Non-GAAP adjusted net income attributable to Ingredion | $ | 115 | $ | 1.73 | $ | 113 | $ | 1.67 | $ | 389 | $ | 5.80 | $ | 378 | $ | 5.58 | |||||||||||
| Net income, EPS and tax rates may not foot or recalculate due to rounding. | |||||||||||||||||||||||||||
| Notes | |||||||||||||||||||||||||||
| (i) During the nine months ended September 30, 2022, we recorded $1 million of pre-tax acquisition and integration charges related to our acquisition and integration of KaTech, as well as our investment in the Argentina joint venture.
During the three and nine months ended September 30, 2021, we recorded $3 million and $1 million of pre-tax net acquisition and integration charges, respectively, related to our investments in the Amyris and Argentina joint ventures, as well as our acquisition of PureCircle Limited. |
|||||||||||||||||||||||||||
| (ii) During the nine months ended September 30, 2022, we recorded $4 million of remaining pre-tax restructuring-related charges for the Cost Smart program.
During the three and nine months ended September 30, 2021, we recorded pre-tax restructuring-related charges of $8 million and $22 million, respectively, primarily related to our Cost Smart programs. The $22 million of charges for the nine months ended September 30, 2022 are net of a $5 million gain on the sale of Stockton, California land and building that occurred during the second quarter of 2021. |
|||||||||||||||||||||||||||
| (iii) During the nine months ended September 30, 2021, we recorded a $340 million net asset impairment charge related to the contribution of Ingredion’s Argentina operations to the Argentina joint venture. The impairment charge reflected a $29 million write-down to the agreed upon fair value of certain Argentina, Chile and Uruguay assets and liabilities contributed and a $311 million write-off of the cumulative translation losses related to the contributed net assets. During the three months ended September 30, 2021, we recorded a $20 million favorable adjustment to the impairment upon finalization of the transaction, which reduced the $360 million asset impairment charge recorded during the first quarter of 2021. | |||||||||||||||||||||||||||
| (iv) During the three months ended September 30, 2022, we recorded pre-tax charges of $9 million primarily related to the impacts of a U.S.-based work stoppage.
During the nine months ended September 30, 2021, we recorded a pre-tax benefit of $15 million to reflect a ruling the Brazilian Supreme Court issued in May 2021 that affirmed that we were entitled to certain indirect taxes. |
|||||||||||||||||||||||||||
| (v) We recorded tax benefits of $1 million and $2 million for the three and nine months ended September 30, 2022, respectively, and tax provisions of $5 million and $4 million for the three and nine months ended September 30, 2021, respectively, as a result of the movement of the Mexican peso against the U.S. dollar and its impact on the remeasurement of the Company’s Mexico financial statements during the periods. | |||||||||||||||||||||||||||
| (vi) This item relates to prior year tax liabilities and contingencies, the reversal of tax liabilities related to certain unremitted earnings from foreign subsidiaries, and tax results of the above non-GAAP addbacks. | |||||||||||||||||||||||||||
| Ingredion Incorporated |
||||||||||||
| Reconciliation of GAAP Operating Income to Non-GAAP Adjusted Operating Income | ||||||||||||
| (Unaudited) |
||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||
| September 30, | September 30, | |||||||||||
| (in millions, pre-tax) | 2022 | 2021 | 2022 | 2021 | ||||||||
| Operating income | $ | 182 | $ | 172 | $ | 605 | $ | 224 | ||||
| Add back: | ||||||||||||
| Acquisition/integration costs (i) | – | 3 | 1 | 1 | ||||||||
| Restructuring/impairment charges (ii) | – | 8 | 4 | 22 | ||||||||
| Impairment on disposition of assets (iii) | – | (20 | ) | – | 340 | |||||||
| Other matters (iv) | 9 | – | 9 | (15 | ) | |||||||
| Non-GAAP adjusted operating income | $ | 191 | $ | 163 | $ | 619 | $ | 572 | ||||
| For notes (i) through (iv), see notes (i) through (iv) included in the Reconciliation of GAAP Net Income attributable to Ingredion and Diluted EPS to Non-GAAP Adjusted Net Income attributable to Ingredion and Adjusted Diluted EPS. | ||||||||||||
| II. Non-GAAP Information (continued) | ||||||||||||||||||||||
| Ingredion Incorporated | ||||||||||||||||||||||
| Reconciliation of GAAP Effective Income Tax Rate to Non-GAAP Adjusted Effective Income Tax Rate | ||||||||||||||||||||||
| (Unaudited) | ||||||||||||||||||||||
| Three Months Ended September 30, 2022 | Nine Months Ended September 30, 2022 | |||||||||||||||||||||
| Income before | Provision for | Effective Income | Income before | Provision for | Effective Income | |||||||||||||||||
| (in millions) | Income Taxes (a) | Income Taxes (b) | Tax Rate (b / a) | Income Taxes (a) | Income Taxes (b) | Tax Rate (b / a) | ||||||||||||||||
| As Reported | $ | 161 | $ | 52 | 32.3 | % | $ | 544 | $ | 157 | 28.9 | % | ||||||||||
| Add back: | ||||||||||||||||||||||
| Acquisition/integration costs (i) | – | – | 1 | – | ||||||||||||||||||
| Restructuring/impairment charges (ii) | – | – | 4 | 1 | ||||||||||||||||||
| Other matters (iv) | 9 | 2 | 9 | 2 | ||||||||||||||||||
| Tax item – Mexico (v) | – | 1 | – | 2 | ||||||||||||||||||
| Other tax matters (vi) | – | (3 | ) | – | (2 | ) | ||||||||||||||||
| Adjusted Non-GAAP | $ | 170 | $ | 52 | 30.6 | % | $ | 558 | $ | 160 | 28.7 | % | ||||||||||
| Three Months Ended September 30, 2021 | Nine Months Ended September 30, 2021 | |||||||||||||||||||||
| Income before | Provision for | Effective Income | Income before | Provision for | Effective Income | |||||||||||||||||
| (in millions) | Income Taxes (a) | Income Taxes (b) | Tax Rate (b / a) | Income Taxes (a) | Income Taxes (b) | Tax Rate (b / a) | ||||||||||||||||
| As Reported | $ | 153 | $ | 34 | 22.2 | % | $ | 170 | $ | 113 | 66.5 | % | ||||||||||
| Add back: | ||||||||||||||||||||||
| Acquisition/integration costs (i) | 3 | – | 1 | (4 | ) | |||||||||||||||||
| Restructuring/impairment charges (ii) | 8 | 1 | 22 | 5 | ||||||||||||||||||
| Impairment on disposition of assets (iii) | (20 | ) | – | 340 | – | |||||||||||||||||
| Other matters (iv) | – | – | (15 | ) | (5 | ) | ||||||||||||||||
| Tax item – Mexico (v) | – | (5 | ) | – | (4 | ) | ||||||||||||||||
| Other tax matters (vi) | – | 1 | – | 29 | ||||||||||||||||||
| Adjusted Non-GAAP | $ | 144 | $ | 31 | 21.5 | % | $ | 518 | $ | 134 | 25.9 | % | ||||||||||
| For notes (i) through (vi), see notes (i) through (vi) included in the Reconciliation of GAAP Net Income attributable to Ingredion and Diluted EPS to Non-GAAP Adjusted Net Income attributable to Ingredion and Adjusted Diluted EPS. | ||||||||||||||||||||||
| II. Non-GAAP Information (continued) | |||||||||||
| Ingredion Incorporated | |||||||||||
| Reconciliation of Expected GAAP Diluted Earnings per Share (“GAAP EPS”) | |||||||||||
| to Expected Adjusted Diluted Earnings per Share (“Adjusted EPS”) | |||||||||||
| (Unaudited) | |||||||||||
| Expected EPS Range | |||||||||||
| for Full-Year 2022 | |||||||||||
| Low End of Guidance | High End of Guidance | ||||||||||
| GAAP EPS | $ | 6.90 | $ | 7.20 | |||||||
| Add: | |||||||||||
| Acquisition/integration costs (i) | 0.01 | 0.01 | |||||||||
| Restructuring/impairment charges (ii) | 0.05 | 0.05 | |||||||||
| Other matters (iii) | 0.11 | 0.11 | |||||||||
| Tax item – Mexico (iv) | (0.10 | ) | 0.05 | ||||||||
| Other tax matters (v) | 0.03 | 0.03 | |||||||||
| Adjusted EPS | $ | 7.00 | $ | 7.45 | |||||||
| Above is a reconciliation of our expected full-year 2022 diluted EPS to our expected full-year 2022 adjusted diluted EPS. The amounts above may not reflect certain future charges, costs and/or gains that are inherently difficult to predict and estimate due to their unknown timing, effect and/or significance. These amounts include, but are not limited to, adjustments to GAAP EPS for acquisition and integration costs, impairment and restructuring costs, and certain other items. We generally exclude these adjustments from our adjusted EPS guidance. For these reasons, we are more confident in our ability to forecast adjusted EPS than we are in our ability to forecast GAAP EPS. | |||||||||||
| These adjustments to GAAP EPS for 2022 include the following: | |||||||||||
| (i) Acquisition and integration charges for our acquisition and integration of KaTech, as well as our investment in the Argentina joint venture. | |||||||||||
| (ii) Remaining restructuring-related charges for the Cost Smart programs. | |||||||||||
| (iii) Charges to date primarily related to the impacts of a U.S.-based work stoppage. | |||||||||||
| (iv) Tax (benefit) expense as a result of the movement of the Mexican peso against the U.S. dollar and its impact on the remeasurement of the Company’s Mexico financial statements during the period. | |||||||||||
| (v) This item relates to prior year tax liabilities and contingencies. | |||||||||||
| II. Non-GAAP Information (continued) | ||||||||||
| Ingredion Incorporated | ||||||||||
| Reconciliation of Expected U.S. GAAP Effective Tax Rate (“GAAP ETR”) | ||||||||||
| to Expected Adjusted Effective Tax Rate (“Adjusted ETR”) | ||||||||||
| (Unaudited) | ||||||||||
| Expected Effective Tax Rate Range | ||||||||||
| for Full-Year 2022 | ||||||||||
| Low End of Guidance | High End of Guidance | |||||||||
| GAAP ETR | 28.0 | % | 31.5 | % | ||||||
| Add: | ||||||||||
| Acquisition/integration costs (i) | – | % | – | % | ||||||
| Restructuring/impairment charges (ii) | 0.2 | % | 0.2 | % | ||||||
| Other matters (iii) | 0.3 | % | 0.3 | % | ||||||
| Tax item – Mexico (iv) | 1.0 | % | (1.5 | ) | % | |||||
| Other Tax Matters (v) | (0.2 | ) | % | (0.2 | ) | % | ||||
| Impact of adjustment on Effective Tax Rate (vi) | (0.8 | ) | % | (0.8 | ) | % | ||||
| Adjusted ETR | 28.5 | % | – | 29.5 | % | |||||
| Above is a reconciliation of our expected full-year 2022 GAAP ETR to our expected full-year 2022 adjusted ETR. The amounts above may not reflect certain future charges, costs and/or gains that are inherently difficult to predict and estimate due to their unknown timing, effect and/or significance. These amounts include, but are not limited to, adjustments to GAAP ETR for acquisition and integration costs, impairment and restructuring costs, and certain other items. We generally exclude these adjustments from our adjusted ETR guidance. For these reasons, we are more confident in our ability to forecast adjusted ETR than we are in our ability to forecast GAAP ETR. | ||||||||||
| These adjustments to GAAP ETR for 2022 include the following: | ||||||||||
| (i) Tax impact on acquisition and integration charges for our acquisition and integration of KaTech, as well as our investment in the Argentina joint venture. | ||||||||||
| (ii) Tax impact on remaining restructuring-related charges for the Cost Smart programs. | ||||||||||
| (iii) Tax impact primarily on charges to date related to the impacts of a U.S.-based work stoppage. | ||||||||||
| (iv) Tax benefit (expense) as a result of the movement of the Mexican peso against the U.S. dollar and its impact to the remeasurement of the Company’s Mexico financial statements during the periods. | ||||||||||
| (v) This item relates to prior year tax liabilities and contingencies. | ||||||||||
| (vi) Indirect impact of tax rate after items (i), (ii), and (iii). | ||||||||||
CONTACTS:
Investors: Noah Weiss, 773-896-5242
Media: Becca Hary, 708-551-2602
GlobeNewswire Distribution ID 8688226